Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on German News Wire.
Press releases published on April 1, 2025
XIMEA Reveals Medium Format Camera with 4.1" IMX811 Sensor: Highest Resolution - 245 Mpix
GlobeNewswire
·
April 1, 2025
MUENSTER, Germany, April 01, 2025 (GLOBE NEWSWIRE) -- XIMEA, the innovator of high-resolution cameras with a unique feature set, expands the xiX-XL family by introducing the currently highest resolution cameras using a backside illuminated Sony IMX811 …
Advanced Medical Balloons presents results from HYDRA-PMCF study of hygh-tec®, demonstrating high performance and safety
GlobeNewswire
·
April 1, 2025
HYDRA-PMCF-study evaluated hygh-tec®, a new polyurethane fecal management system hygh-tec® showed a high level of sealing performance (no leakage in 89.3%) and was safe to use (94.2% no signs of infection; GLOBIAD score = 0+1A) Full results will be …
Sernova Biotherapeutics Provides Update on Phase 1/2 Clinical Trial of Cell Pouch™ Bio-Hybrid Organ for Treatment of Type 1 Diabetes
GlobeNewswire
·
April 1, 2025
DSMB supports advancement for Sernova’s clinical trial Study is on track to meet key clinical trial endpoints LONDON, Ontario and BOSTON, April 01, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics, (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a leading …
Lifeist Prepares to Unveil Major Brand Refresh and Product Expansion for Mikra, Highlighting New Collaborations and Cognitive Health Focus
GlobeNewswire
·
April 1, 2025
TORONTO, April 01, 2025 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSX.V: LFST; FRANKFURT: M5B0; OTCMKTS: LFSWF), a leading health and wellness company focused on acquiring, integrating, and building top wellness brands, is …
Revive Therapeutics Announces Acquisition of Molecular Hydrogen Program
GlobeNewswire
·
April 1, 2025
TORONTO, April 01, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for infectious diseases, …
Sysmex’s PA-100 AST System: Revolutionising UTI diagnosis and treatment with precision
GlobeNewswire
·
April 1, 2025
PARIS, April 01, 2025 (GLOBE NEWSWIRE) -- Sysmex’s PA-100 AST System is redefining standard of care for diagnosing and treating urinary tract infections (UTIs). By combining cutting-edge nanofluidic technology with rapid antimicrobial susceptibility …
Le Système PA-100 AST de Sysmex : Révolutionner le diagnostic et le traitement des IU avec précision
GlobeNewswire
·
April 1, 2025
PARIS, 01 avr. 2025 (GLOBE NEWSWIRE) -- Le Système PA-100 AST de Sysmex redéfinit les normes de soins pour le diagnostic et le traitement des infections urinaires (IU). En associant une technologie nanofluidique de pointe à un antibiogramme rapide, le …
ITM Appoints Dr. Celine Wilke as Chief Medical Officer
GlobeNewswire
·
April 1, 2025
Experienced leader in radiopharmaceutical drug development, regulatory, and clinical strategies will advance ITM’s broad pipeline and clinical development strategy Garching / Munich, Germany, April 01, 2025 – ITM Isotope Technologies Munich SE (ITM), a …
PyroGenesis Announces Fourth Quarter and Full Year 2024 Results
GlobeNewswire
·
April 1, 2025
Quarterly Revenue of $4.22 Million, Up 40% Year-Over-Year. Quarterly Net Income of $145,320. Full Year Revenue of $15.7 Million, Up 27% Year-Over-Year. Backlog of $54.4 Million, with 87% in U.S. Dollars. Revenue Growth Expected to Continue as 2025 Opens …